Some insurance companies may require prior authorization proving medical necessity prior to paying for treatment
The most important current difference is regulatory: Wegovy is licensed to reduce cardiovascular risk, whereas tirzepatides cardiovascular licence is still being assessed
All trademarks and registered trademarks referenced belong to their respective owners and are used for informational purposes only
REFERENCES Agarwal A, Allamaneni SS
The damaging effects of proinflammatory CK were described and characterized in rat [66] or cARLA treated human BBB models [40]
This commenter stated, that because e.g. is used to identify an example of an inclusive universe, rather than narrowing or defining the general category of device to that specifically named device, providers suggest that other devices ( beyond the brand name product may qualifydespite the additional parenthetical stating the device must be a qualifying device under section 4135 of the CAA, 2023